{"schema_version":"secwatch.filing_event.v1","accession":"0001393905-24-000378","form_type":"8-K","ticker":"STME","cik":"0001493712","company_name":"Stimcell Energetics Inc.","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.578934+00:00","generated_at":"2026-05-30T05:18:09.504811+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics","bullets":["Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.","Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.","Name changed from Cell MedX Corp. to Stimcell Energetics Inc.","Symbol will trade as \"CMXCD\" for 20 business days starting Nov 5, then seek new symbol.","New website launched at www.StimCell.com for investor and clinical trial info."],"urls":{"canonical":"https://secwatch.observer/filing/0001393905-24-000378","json":"https://secwatch.observer/filing/0001393905-24-000378.json","markdown":"https://secwatch.observer/filing/0001393905-24-000378.md","text":"https://secwatch.observer/filing/0001393905-24-000378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/0001393905-24-000378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/cmxc-20241101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:18:09.504811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}